WebHigh-osmolar contrast media (HOCM) are the oldest agents. They are relatively inexpensive, but their utility is limited. They are monomers (single benzene ring) that ionize in solution with a valence of -1. Their cation is either sodium or meglumine. A major advance was the development of nonionic compounds. They are WebIodixanol, a nonionic, dimeric contrast medium, is iso-osmolar to blood at all concentrations, and its level of general toxicity is lower than that of low-osmolar contrast mediums. 21-23 Extensive ...
Label and Warnings 0407-2222 Visipaque - ndclist.com
Web1 jan. 2009 · However, in patients with intraarterial administration and renal insufficiency, iodixanol is associated with a reduced risk of CIN compared with iohexol, whereas no significant difference between iodixanol and other LOCM could be found. © RSNA, 2009 Article History Published in print: 2009 Figures References Vol. 250, No. 1 Metrics PDF … Web1 mrt. 2011 · Purpose To prospectively compare the effect of intravenous injection of low-osmolar iopamidol with that of intravenous injection of iso-osmolar iodixanol on heart rate (HR) during nongated chest computed tomographic (CT) … cshtml table 動的
Nephrotoxicity in High-Risk Patients Study of IsoOsmolar and Low ...
Web11.1 Chemical Characteristics. VISIPAQUE (iodixanol) injection is a dimeric, iso-osmolar, nonionic, water-soluble, radiographic contrast medium for intravascular (intravenous and intra-arterial) use. It is provided as a ready-to-use sterile, pyrogen-free, and preservative free, colorless to pale yellow solution. Web20 mei 2024 · There are two major ionic agents on the market, differing in the R-group: The osmolarity of ionic agents depends on the concentration, which typically ranges from … Web20 mrt. 2024 · Purpose This study was conducted to compare iso-osmolar contrast medium, iodixanol, with low-osmolar contrast media (LOCM) for assessing contrast-induced nephropathy (CIN) incidence, exclusively in the diabetic population. Method A systematic search was conducted for full-text, prospective, randomized controlled trials … cshtml styling